MiMedx Group share price logo

MiMedx Group

NASDAQ: MDXG

Small Cap

$4.30

+0.11

(+2.74%)

Live

as on

MiMedx Group Stock Performance

as on August 19, 2026 at 6:13 am IST

  • Day's Low

    Day's High

    $4.20
    $4.37
    downward going graph

    2.33%

    Downside

    1.63%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.03
    $7.97
    downward going graph

    29.65%

    Downside

    85.35%

    Upside

    downward going graph

MiMedx Group share price movements today

Previous Close
$4.19
Open
$4.20
Volume
1.4M
Market Cap
$622.4M
Day's Low - High
$4.20 - $4.37
52 Week Low - High
$3.03 - $7.97

MiMedx Group Historical Returns

1 Month Return
-0.7 %
3 Month Return
+ 19.94 %
1 Year Return
-39.94 %
3 Year Return
-41.59 %
5 Year Return
-64.91 %

MiMedx Group Stock Fundamentals & Key Indicators

Check MiMedx Group market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$622.4M

EPS (TTM)

0.04

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.99%

PE Ratio (TTM)

105

Industry PE ratio

-7.283372093023256

PEG Ratio

-1.2833333333333334

EBITDA

23.7M

Revenue (TTM)

355.2M

Profit Margin

78.85%

Return On Equity TTM

2.61%

MiMedx Group Stock Valuation

Track how MiMedx Group P/E has moved over time to understand its valuation trends.

MiMedx Group in the last 5 years

  • Overview

  • Trends

Lowest (-54.19x)

December 31, 2021

Industry (-7.28x)

December 31, 2025

Today (20.52x)

December 31, 2025

Highest (33.17x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 20.52x

MiMedx Group vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of MiMedx Group with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
MiMedx Group image
MiMedx Group
BUY$622.4M-64.91%10578.85%NA
Revolution Medicines image
Revolution Medicines
BUY$43.7B669.3%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$128.2B154.86%29.8286.04%NA
Regeneron image
Regeneron
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for MiMedx Group Stock including INR - Dollar returns

The MiMedx Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 10Y

MiMedx Group investment value today

Current value as on today

₹66,268

Returns

-₹33,732

(-33.73%)

Returns from MiMedx Group Stock

-₹39,522 (-39.52%)

Dollar Impact

₹5,790 (+5.79%)

Analyst Recommendation on MiMedx Group Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for MiMedx Group. Average target price of $7

MiMedx Group Share Price Target

Get share price movements and forecasts by analysts on MiMedx Group.

What analysts predicted

38.57%UPSIDE

Target Price

$7

Current Price

$4.3

Analyzed by

2 Analysts

Target

$7.00

MiMedx Group target price $7, a slight upside of 38.57% compared to current price of $4.3. According to 2 analysts rating.

Indian Investors' Interest in MiMedx Group Stock

Search interest for MiMedx Group Stock has increased by 9% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:9% versus previous 30 day period

MiMedx Group Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
84
87
84
92
88
98
113
118
58
64
Gross Profit
71
72
68
75
71
79
95
99
41
44
Operating Income
13
23
11
11
8
12
22
21
-16
-18
EBITDA
14
24
12
14
12
16
28
25
-13
-16
Interest Expense
1
0
-
2
0
0
0
0
0
-
Depreciation
0
1
1
2
3
3
5
3
1
1
Income Before Tax
11
23
11
11
8
13
22
21
-15
-17
Income Tax Expense
2
5
3
3
1
3
6
6
-4
-2
Net Income
9
17
8
7
7
9
16
15
-10
-14
Net Profit Margin
84.45%
82.75%
81.77%
81.80%
81.23%
81.05%
83.54%
83.86%
70.56%
68.96%

MiMedx Group Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Jun 2020
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
321
359
299
248
242
267
321
348
418
Gross Profit
285
322
256
208
202
219
266
288
345
Operating Income
46
-3
-21
-45
-7
-14
37
58
63
EBITDA
52
17
-13
-37
-1
-10
40
65
82
Interest Expense
0
-
4
7
4
5
6
1
1
Depreciation
5
6
7
6
5
4
3
6
14
Income Before Tax
45
-3
-25
-61
-12
-19
30
57
66
Income Tax Expense
-19
26
0
-12
0
0
-36
15
17
Net Income
64
-29
-25
-49
-12
-30
67
42
48
Net Profit Margin
89.03%
89.87%
85.60%
84.16%
83.63%
81.96%
83.01%
82.78%
82.56%

MiMedx Group Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
9
17
7
7
7
9
16
15
-10
-14
Operating Cash Flow
5
21
19
18
5
14
29
24
1
-10
Investing Cash Flow
-6
0
0
-2
0
0
-5
0
-5
0
Financing Cash Flow
-33
0
0
0
-2
-1
0
0
-2
-13
Change in Cash
-33
20
19
15
2
12
23
24
-6
-23

MiMedx Group Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Jun 2020
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
64
-29
-25
-49
-12
-19
67
41
48
Operating Cash Flow
62
35
-39
-30
-1
-17
26
66
74
Investing Cash Flow
-5
-9
0
-4
-3
-2
-2
-9
-6
Financing Cash Flow
-60
-8
62
61
-3
0
-8
-34
-5
Change in Cash
-2
17
23
26
-8
-21
16
22
61

Mutual Funds that own MiMedx Group Stock

Check out the Mutual Funds with significant holdings in MiMedx Group.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.457994%
5040389
Fidelity Salem Street Trust
0.872529%
1271803
Fidelity Concord Street Trust
0.820707%
1196267
DFA INVESTMENT DIMENSIONS GROUP INC
0.752293%
1096546
SCHWAB CAPITAL TRUST
0.612758%
893160
See all

Global Institutional Holdings in MiMedx Group

Funds
Holdings
Vanguard
4.31%
iShares
3.68%
SPDR
2.37%
Dimensional
0.81%
Avantis
0.52%
See all

Insights on MiMedx Group

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 58.99M → 64.36M (in $), with an average increase of 8.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 615.7% return, outperforming this stock by 659.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 481.6% return, outperforming this stock by 523.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, MDXG stock has moved down by -41.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 16.74M → -14.84M (in $), with an average decrease of 72.5% per quarter

About MiMedx Group

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, EPIXPRESS, CHORIOFIX, EMERGE, CELERA, REGENKIT WOUND GEL, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the size of the wound to reduce product waste. Its surgical and other product offerings consist of AMNIOFIX, AMNIOBURN, AMNIOCORD, AXIOFILL, HELIOGEN, and AMNIOEFFECT for applications in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery, and various orthopedic repairs and reconstructions. The company's products are used in the areas of wound care, burn, and surgical fields in healthcare. It sells its products through direct sales force and independent sales agents, as well as to individual customers and independent distributors in the United States. The company has a strategic alliance with Vaporox, Inc. for the promotion of their wound care offerings. The company was founded in 2006 and is headquartered in Marietta, Georgia.
OrganisationMiMedx Group
Headquarters1775 West Oak Commons Court, NE, Marietta, GA, United States, 30062
IndustryBiotechnology
CEOMr. Joseph H. Capper
E-voting on sharesClick here to vote

Key Management of MiMedx Group

Name

Title

Mr. Joseph H. Capper

CEO & Director

Mr. Matthew M. Notarianni

Head of Investor Relations

Ms. Hilary Dixon

Vice President of Investor Relations & Corporate Strategic Communications

Mr. Eric A. Smith

Senior VP of Marketing & International

Ms. Tracy Chastain

Chief Human Resources Officer

Mr. Douglas C. Rice CPA

Chief Financial Officer

Mr. William F. Hulse IV

General Counsel & Chief Administrative Officer

Ms. Kimberly Maersk-Moller

Chief Commercial Officer

Dr. John Harper Ph.D.

SVP of R&D & Medical Affairs and Chief Scientific Officer

Mr. Mark P. Graves

Senior VP & Chief Compliance Officer

FAQs

What is MiMedx Group share price today?

MiMedx Group share price today is $4.30 as on . MiMedx Group share today touched a day high of $4.37 and a low of $4.20.

What is the 52 week high and 52 week low for MiMedx Group share?

MiMedx Group share touched a 52 week high of $7.97 on and a 52 week low of $3.03 on . MiMedx Group stock price today i.e. is trending at $4.30,which is 46.05% down from its 52 week high and 42.15% up from its 52 week low.

What is MiMedx Group's market capitalisation today?

MiMedx Group market capitalisation is $0.00T as on .

How to invest in MiMedx Group Stock (MDXG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for MiMedx Group on INDmoney app. Click on Buy button. You can invest as low as $1.5 in MiMedx Group Shares that will get you 0.3488 shares as per MiMedx Group share price of $4.30 per share as on August 19, 2026 at 12:43 am IST.

What is the minimum amount required to buy MiMedx Group Stock (MDXG) from India?

Indian investors can start investing in MiMedx Group (MDXG) shares with as little as ₹95.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.70 in MiMedx Group stock (as per the Rupee-Dollar exchange rate as on ). Based on MiMedx Group share’s latest price of $4.30 as on August 19, 2026 at 12:43 am IST, you will get 2.3256 shares of MiMedx Group. Learn more about fractional shares .

What are the returns that MiMedx Group has given to Indian investors in the last 5 years?

MiMedx Group stock has given -64.91% share price returns and 28.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?